TGFB1 and breast cancer: Multiple integrin receptors (integrin α2, αL, αM, αV, β2, β6) were shown to mediate the process by which ICAM1 promotes bone metastasis in breast cancer through TGF-β/SMAD/epithelial-to-mesenchymal transition signaling [131].